Clinical Equivalence Study of Mometasone Nasal Spray

PHASE3CompletedINTERVENTIONAL
Enrollment

880

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

placebo

DRUG

Mometasone Nasal Spray

DRUG

Mometasone nasal spray

Trial Locations (25)

Unknown

Investigator site 18, Stockbridge

Investigator site 1, Louisville

Investigator site 3, Bethesda

Investigator Site 19, Minneapolis

Investigator Site 24, St Louis

Investigator site 22, Bellevue

Investigator Site 23, Skillman

Investigator site 2, Corning

Investigator site 9, High Point

Investigator site 20, Raleigh

Investigator site 25, Cincinnati

Investigator site 21, Sylvania

Investigator site 16, Spartanburg

Investigator Site 10, Austin

Investigator Site 12, Austin

Investigator site 6, Austin

Investigator Site 11, Kerrville

Investigator Site 7, New Braunfels

Investigator Site 13, San Antonio

Investigator site 14, San Antonio

Investigator site 5, San Antonio

Investigator site 8, San Antonio

Investigator site 4, Waco

Investigator Site 15, Draper

Investigator Site 17, Greenfield

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Watson Laboratories, Inc.

INDUSTRY

lead

Actavis Inc.

INDUSTRY

NCT01850823 - Clinical Equivalence Study of Mometasone Nasal Spray | Biotech Hunter | Biotech Hunter